OctoPlus Shares Surge After Dr. Reddy's $36M Buyout Bid
By Cormac Sheridan
Monday, October 22, 2012
The management of Dutch drug delivery specialist OctoPlus NV agreed to a €27.4 million (US$35.8 million) cash offer from Indian generics firm Dr. Reddy's Laboratories Ltd.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.